|
BHC
|
Bausch Health Companies Inc.
|
US
|
NYSE
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
FNCH
|
Finch Therapeutics Group, Inc.
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
US
|
NASDAQ
|
|
HCM
|
Hutchison China MediTech Limited
|
US
|
NASDAQ
|
|
IMUX
|
Immunic, Inc.
|
US
|
NASDAQ
|
|
JAGX
|
Jaguar Animal Health, Inc.
|
US
|
NASDAQ
|
|
LABP
|
Landos Biopharma, Inc.
|
US
|
NASDAQ
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MCRB
|
Seres Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
US
|
NASDAQ
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
US
|
NASDAQ
|
|
VBLT
|
Vascular Biogenics Ltd.
|
US
|
NASDAQ
|
|
IMC
|
Immuron Limited
|
AU
|
ASX
|
|
BGLC
|
Bionexus Gene Lab Corp
|
US
|
OTC
|
|
CHSYF
|
China Medical Sys Hlds
|
US
|
OTC
|
|
GLPGF
|
Galapagos Genomics Ord
|
US
|
OTC
|
|
IVBXF
|
Innovent Biologics Inc
|
US
|
OTC
|
|
BHC
|
Bausch Health Companies Inc.
|
CA
|
TSX
|
|
GSD
|
Devonian Health Group Inc
|
CA
|
TSXV
|